MAP2K7 and acute lymphoblastic leukemia: Thus we posit that the mechanism by which MEKi and BCL-2i cooperated to kill B-ALL cells was that MEK inhibition caused BIM dephosphorylation and upregulation at the protein level, allowing BIM to bind to and neutralize MCL-1, removing one survival signal.